Listen to Prof Nicoletta Colombo and Bradley J. Monk, MD, FACS, FACOG, discuss current best practices for biomarker testing for your patients with advanced ovarian cancer.

In this episode, Prof Nicoletta Colombo and Bradley J. Monk, MD, FACS, FACOG, discuss current best practices for biomarker testing in the management of patients with advanced ovarian cancer. Topics include:

Subtypes of ovarian cancer
BRCA mutation testing
Homologous recombination deficiency testing

Presenters:

Professor Nicoletta Colombo
Professor of Obstetrics and Gynecology
University of Milan-Bicocca
European Institute of Oncology
Milan, Italy

Bradley J. Monk MD, FACS, FACOG
Professor
Division of Gynecologic Oncology
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine--Phoenix
Creighton University School of Medicine at St Joseph's Hospital
Phoenix, Arizona

Content based on an online CME program supported by an educational grant from GlaxoSmithKline.

Link to full program:
https://bit.ly/2Scnp2N

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond